Some of the areas of research and development of the GRIB which are particularly appreciated by our clients are:

• Computational discovery of drug targets
• The creation and exploitation of molecular libraries biologically annotated
• In silico methods for drug safety assessment
• Virtual screening in drug discovery
• The computational prediction of the biological properties of drugs (efficacy, toxicity, side effects, etc.)
• Knowledge management and linked data
• Systems biology and network medicine for the study of human diseases and drug toxicity